David Connor

University of New South Wales

Australia

Research Interests

Explore related searches

Professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (18)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (7)

Freda H. Passam

AUSTRALIA

View details

Christine Lee

Australian National University

AUSTRALIA

View details

Joanne Joseph

University of New South Wales

AUSTRALIA

View details

Christopher Rogan

Head of Department

Chris O'Brien Lifehouse

AUSTRALIA

View details

Alun H Davies

Imperial College London

UNITED KINGDOM

View details

Wendy Bonython

Bond University

AUSTRALIA

View details

Neil Piller

Flinders University

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

David Connor

Research Interests

Explore related searches

Contact this professor

Articles (18)

Authors reply: 899 serious adverse events including 13 deaths, 7 strokes, 211 thromboembolic events, and 482 immune reactions: The untold story of cyanoacrylate adhesive closure

Higher soluble thrombomodulin and angiogenic markers in continuous flow left ventricular assist device–supported patients associated with arteriovenous malformation and nonsurgical bleeding

Authors reply: Polymerisation of cyanoacrylates: The effect of sclero-embolic and contrast agents

Guidelines for management of actual or suspected inadvertent intra-arterial injection of sclerosants

Diagnosis of post-thrombotic syndrome: International union of phlebology (UIP) survey of medical specialists

899 serious adverse events including 13 deaths, 7 strokes, 211 thromboembolic events, and 482 immune reactions: The untold story of cyanoacrylate adhesive closure

Polymerisation of cyanoacrylates: The effect of sclero-embolic and contrast agents

Australasian College of Phlebology Scientific meeting: Debates and Consensus in Fiji

XXIII Australasian College of Phlebology meeting synopsis

Pigmentation of lower limbs: Contribution of haemosiderin and melanin in chronic venous insufficiency and related disorders

Sclerotherapy of lower limb veins: Indications, contraindications and treatment strategies to prevent complications – A consensus document of the International Union of Phlebology-2023

Authors Reply: Chronic venous disease, platelet and haemostatic abnormalities contribute to the pathogenesis of pigmented purpuric dermatoses

A novel flow cytometry procoagulant assay for diagnosis of vaccine-induced immune thrombotic thrombocytopenia.

Skin necrosis following sclerotherapy. Part 2: Risk minimisation and management strategies

Skin necrosis following sclerotherapy. Part 1: Differential diagnosis based on classification of pathogenic mechanisms

Chronic venous disease, platelet and haemostatic abnormalities contribute to the pathogenesis of pigmented purpuric dermatoses

Treatment of venous malformations with tumescent-assisted sclero-embolic and ablative lasers (SEALs): Safe and effective long-term outcomes

The utility of flow cytometric platelet forward scatter as an alternative to mean platelet volume.

Collaborators (7)

Freda H. Passam

Christine Lee

Joanne Joseph

Christopher Rogan

Alun H Davies

Wendy Bonython

Neil Piller

Make your next move.